An ode to a monumental film — and a lesson for 2025
When Marcel Ophuls released his documentary 'Le Chagrin et la Pitié' in France decades ago (it reached the U.S. as 'The Sorrow and the Pity'), French authorities denounced the monumental film. They saw it as a radical attack on mainstream French culture and postwar nationhood. By revealing the extensive collaboration by conservative French society with the Nazi occupation in World War II, Ophuls was seen as taking the side of leftists whose anti-government protests had reached a peak in the Paris streets in 1968.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Eater
4 minutes ago
- Eater
Norman's Japanese Grill Breaks All the Rules
'I think as the concept developed, to be a Western Japanese restaurant, it gave us license to do whatever fits in that box,' Duro co-founder Chas Martin says. 'And it's a pretty big box.' Interestingly, the idea of how to interweave the two came from Duro partner Corbin See, who pointed out that Japan has a niche country music scene and appreciation for cowboy culture as presented in old films and television, influenced by the Allied Forces occupation of Japan following World War II. 'He brought this concept up, of all of these Japanese designers who were heavily inspired by 'the Wild Wild West' and underground dive bars inspired by Texas honky tonks,' says Martin. Eater sat down with Martin and Jared Harms, Duro's culinary director, to learn about five dishes on the menu at Norman's. Edamame hummus with pear chutney. Kathy Tran Edamame hummus Harms: 'It's edamame with fresh jalapeño, which we have to blend three times to get to the correct consistency. We go from a food processor into a Vitamix, and the end result is a little granular. It's vegan and craveable, and punchy in the center, where it has an aromatic plum chutney that has a lot of herby, sweet, and acidic flavors to it. We went through a lot of phases of figuring out which crispy things to use to dip. Ultimately, we went with wonton chips dusted with our shichimi togarashi [a Japanese spice blend of chile pepper, sesame seeds, orange peel, poppy seeds, ginger, and sometimes nori seaweed]. It's a pretty way to start the meal. The chips stay in our dehydrator and are warm all through service.' Hamachi meets tom kha sauce in this crudo. Kathy Tran Cold-smoked hamachi Harms: 'I'm a big fan of the way the pureness of the tom kha sauce in this hamachi plays with the fish caramel, along with the sweetness of the papaya and charred shiitake mushrooms. This plate came together over six or seven tastings, and the final is the best variation. We knew we wanted to do crudo our way. More than anything, we wanted to make sure you could taste the fish. Tom kha isn't Japanese, but it is part of the culture of chef Benjamin Norton, who runs the kitchen at Norman's, and this is a recipe he has worked with for his entire career.' The oils are the secret to transforming this carbonara into a Japanese-inspired dish. Kathy Tran Udon carbonara Harms: 'It's a nod to our love of noodles, and is a nod to our first restaurant, the Charles, which is always in our hearts. Of course, there is a twist in the carbonara. It has egg yolks cured in tare, shiro dashi [a Japanese soup base made with white soy sauce, kombu, and bonito], dashi, and black pepper. There is also pancetta that is diced large and rendered daily. If you want to, you can use a fork to eat it and twirl it. There are pickled mustard greens in it as well, along with fresh lemon juice.' You can eat these noodles with chopsticks. Kathy Tran Martin: 'The pickled mustard greens were, to me, the aha moment of this dish, when we all were like, That's the best.' One of the rule breaking dishes is this Korean fried chicken. Kathy Tran Korean fried chicken Harms: 'This dish began as an idea for karaage chicken, but it evolved. The best iteration of the dish wasn't a dry batter, but the wet batter was what we liked best. It has been the most consistently delicious. Chef Ben Norton, who is half Korean, wanted to bring his mom's gochujang sauce to Norman's. The chicken gets tossed in that sauce, pseudo hot chicken-style, but only about 80 percent, so you still get extra-crispy bites. The plate also has pickled cucumbers, negi [long green onions], and toasted sesame seeds.' Cowboy rib-eye with a Southeast Asian salad — that's about as Japanese Western as it gets. Kathy Tran Dry-aged cowboy rib-eye Harms: 'Having a papaya salad with a big, fatty rib-eye was an idea from the beginning. We loved the punchy, spicy, acidic, and crunch accompaniment with a fatty, crusty steak. We weren't always planning to use dry-aged meat, but it worked out well. We are using a 45-day dry-aged cut that gets crusted with salt and black pepper on the grill. We brush it with tare glaze as a last step before it comes off the grill. The way those two flavors dance together is amazing, as is electing to add honey butter torched tableside.' Martin: 'We kept the grill from Homewood, so that's a massive component of the cooking here.' The sushi counter spread. Kathy Tran If you only order one piece of sushi: Make it the bluefin tuna with foie gras shredded over it. Norman's has three sushi chefs. 'We use the otoro, the fattiest part, and top it with pickled red pearl onion, crispy garlic, and then hit it with frozen foie gras.' Pro-tip from Martin: You have to order the Crazy 88, a mezcal margarita with wasabi and lemongrass. Norman's Japanese Grill is open now at 4002 Oak Lawn Avenue in Dallas, serving dinner. Reservations can be made on OpenTable.
Yahoo
33 minutes ago
- Yahoo
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
33 minutes ago
- Yahoo
Book Review: 'The Devil Reached Toward the Sky' weaves thorough account of Atomic Age's start
The story of the Atomic Age's start is a fascinating one about the power of invention and a chilling one about its consequences. In 'The Devil Reached Toward the Sky: An Oral History of the Making and Unleashing of the Atomic Bomb,' Garrett M. Graff skillfully tells both. The power of Graff's oral history is the diversity of voices he relies upon in crafting a comprehensive history of the atomic bomb's inception, creation and use during World War II. He creates a comprehensive account of a what seems like a well-told piece of history by including voices that have been either little-heard or missed altogether in the six decades since the atomic bombs were dropped on Hiroshima and Nagasaki. Graff at the outset acknowledges his book is adding to a history that feels well-worn, from historian Richard Rhodes to filmmaker Christopher Nolan. But Graff manages to stand up to even those accounts with voices that help the reader help what it was it was like on the ground. It includes life at Los Alamos, New Mexico; Oak Ridge, Tennessee; and Hanford, Washington as scientists raced to develop the atomic bomb before Nazi Germany. 'The Devil Reached Toward the Sky' focuses not just on the voices of scientists like Robert Oppenheimer and Edward Teller. Graff also explores overlooked pieces of the Manhattan Project's history, such as how segregation affected life at Oak Ridge. But the most powerful portions come in the final chapters of the book, which focus on the bombing and the aftereffects of the bombing in Hiroshima and Nagasaki. No writer could describe better the hellscape that the bombs unleashed better than those on the ground who survived it. 'My God, what have we done?,' Capt. Robert A. Lewis, co-pilot of the Enola Gay, is quoted in the book as saying. The voices Graff mines help begin to answer at least part of that question. ___ AP book reviews: Andrew Demillo, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
